Webcast Amylin Pharmaceuticals 2009 ADA Briefing for Investors (Replay) 06/07/09 at 7:45 p.m. CT Webcast Amylin Pharmaceuticals, Inc. at Goldman Sachs Global Healthcare Conference (Replay) 06/09/09 at 10:45 a.m. ET Webcast Amylin Pharmaceuticals, Inc. at Piper Jaffray Europe Conference (Replay) 06/24/09 at 10:30 a.m. UKT Our Investor Relations Center is provided to give you convenient access to company information, including financial reports, press releases and corporate events. You can also sign up to be reminded via email of any upcoming company presentations, or to be notified of news releases and other announcements. If you cannot find the information you're looking for on our website please let us know, and we will do our best to accommodate your request.
Featured Report   2008 Form 10K Receive E-mail Alerts Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!		Stock Quote AMLN (Common) Exchange NASDAQ (US Dollar) Price $12.88 Change (%)   0.54 (4.02%) Volume 2,307,624 Data as of 07/02/09 4:00 p.m. ET Minimum 20 minute delay Refresh quote
Recent News More >> Date Title   06/17/09 Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference 06/08/09 Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 06/07/09 Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009 06/07/09 Interim Study Results Presented at ADA 2009: Exenatide Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.